Literature DB >> 20795860

Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection.

Erin W Norcross1, Nathan A Tullos, Sidney D Taylor, Melissa E Sanders, Mary E Marquart.   

Abstract

PURPOSE: The pneumococcal capsule is required for pathogenesis in systemic infections, yet reports show most conjunctivitis outbreaks are caused by nonencapsulated pneumococci, while keratitis infections are caused by encapsulated strains. This study aims to determine the effect of capsule in pneumococcal keratitis and conjunctivitis in rabbit models of infection.
METHODS: A capsule-deficient isogenic mutant was created using homologous transformation. Parent and mutant strains were injected within the upper bulbar conjunctiva (conjunctivitis) or into the corneal stroma (keratitis) of New Zealand white rabbits. Clinical examinations were performed 24 and 48 hr post-infection at which time corneas or conjunctivae were removed, homogenized, and plated to determine the recovered bacterial load. Whole eyes were removed for histological examination. The neuraminidase activity was determined following in vitro and in vivo growth.
RESULTS: There were no significant differences in clinical scores between the eyes infected with the parent or mutant for either infection, nor was there a difference in the amount of bacteria recovered from the cornea. In the conjunctivae, however, the mutant strain was cleared by the host faster than the parent strain. Histological examination showed slightly more infiltrating polymorphonuclear leukocytes (PMN) and macrophages in the conjunctivae infected with the parent strain. The neuraminidase activity of both strains was not significantly different when the strains were grown in vitro. However, the neuraminidase activity of the parent was significantly less than that of the mutant at 3 and 12 hr post conjunctival infection.
CONCLUSIONS: Although more outbreaks of pneumococcal conjunctivitis are tied to nonencapsulated S. pneumoniae strains, this study showed that an encapsulated strain was capable of establishing conjunctivitis in a rabbit injection model and survive attack by the host immune system longer than its nonencapsulated isogenic mutant. Nonetheless, the nonencapsulated pneumococci had an increased neuraminidase activity level in vivo when compared to the parent strain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20795860      PMCID: PMC2997481          DOI: 10.3109/02713683.2010.492462

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  61 in total

1.  Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells.

Authors:  Sven Hammerschmidt; Sonja Wolff; Andreas Hocke; Simone Rosseau; Ellruth Müller; Manfred Rohde
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Activation of human complement by the pneumococcal toxin pneumolysin.

Authors:  J C Paton; B Rowan-Kelly; A Ferrante
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

3.  An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae.

Authors:  C K Sung; H Li; J P Claverys; D A Morrison
Journal:  Appl Environ Microbiol       Date:  2001-11       Impact factor: 4.792

4.  Requirement for capsule in colonization by Streptococcus pneumoniae.

Authors:  A D Magee; J Yother
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

5.  An outbreak of conjunctivitis due to a novel unencapsulated Streptococcus pneumoniae among military trainees.

Authors:  Nancy F Crum; Christopher P Barrozo; Frank A Chapman; Margaret A K Ryan; Kevin L Russell
Journal:  Clin Infect Dis       Date:  2004-09-27       Impact factor: 9.079

6.  Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype.

Authors:  Catherine Hyams; Jose Yuste; Katie Bax; Emilie Camberlein; Jeffrey N Weiser; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

7.  The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms.

Authors:  Catherine Hyams; Emilie Camberlein; Jonathan M Cohen; Katie Bax; Jeremy S Brown
Journal:  Infect Immun       Date:  2009-11-30       Impact factor: 3.441

8.  Confirmation of the role of pneumolysin in ocular infections with Streptococcus pneumoniae.

Authors:  M K Johnson; J A Hobden; R J O'Callaghan; J M Hill
Journal:  Curr Eye Res       Date:  1992-12       Impact factor: 2.424

9.  Confirmation of nontypeable Streptococcus pneumoniae-like organisms isolated from outbreaks of epidemic conjunctivitis as Streptococcus pneumoniae.

Authors:  Maria Gloria S Carvalho; Arnold G Steigerwalt; Terry Thompson; Delois Jackson; Richard R Facklam
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.

Authors:  Jie Li; Alexander J Szalai; Susan K Hollingshead; Moon H Nahm; David E Briles
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

View more
  17 in total

1.  The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Zachary M Robertson; Quincy C Moore; Jonathan Fratkin; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

2.  Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae Keratitis.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Sidney D Taylor; Nathan A Tullos; Rhonda R Caston; Sherrina N Dixon; Moon H Nahm; Robert L Burton; Hilary Thompson; Larry S McDaniel; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-29       Impact factor: 4.799

3.  Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Mary E Marquart
Journal:  J Bacteriol Parasitol       Date:  2011

4.  Molecular characterization of pneumococcal surface protein K, a potential pneumococcal vaccine antigen.

Authors:  A-Yeung Jang; Ho Seong Seo; Shunmei Lin; Gook-Hyun Chung; Han Wool Kim; Sangyong Lim; Lei Zhao; In Ho Park; Jae Hyang Lim; Kyung-Hyo Kim
Journal:  Virulence       Date:  2017-01-06       Impact factor: 5.882

5.  The Rcs Stress Response System Regulator GumB Modulates Serratia marcescens-Induced Inflammation and Bacterial Proliferation in a Rabbit Keratitis Model and Cytotoxicity In Vitro.

Authors:  Eric G Romanowski; Nicholas A Stella; John E Romanowski; Kathleen A Yates; Deepinder K Dhaliwal; Anthony J St Leger; Robert M Q Shanks
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

Review 6.  Proteomics in the Study of Bacterial Keratitis.

Authors:  Rachida Bouhenni; Jeffrey Dunmire; Theresa Rowe; James Bates
Journal:  Proteomes       Date:  2015-12-14

7.  Infectious keratitis: secreted bacterial proteins that mediate corneal damage.

Authors:  Mary E Marquart; Richard J O'Callaghan
Journal:  J Ophthalmol       Date:  2013-01-08       Impact factor: 1.909

Review 8.  Foundational concepts in the biology of bacterial keratitis.

Authors:  Lawson Ung; James Chodosh
Journal:  Exp Eye Res       Date:  2021-06-05       Impact factor: 3.770

9.  Nonencapsulated Streptococcus pneumoniae as a cause of chronic adenoiditis.

Authors:  Cheshil Dixit; Lance E Keller; Jessica L Bradshaw; D Ashley Robinson; Edwin Swiatlo; Larry S McDaniel
Journal:  IDCases       Date:  2016-04-12

Review 10.  Nonencapsulated Streptococcus pneumoniae: Emergence and Pathogenesis.

Authors:  Lance E Keller; D Ashley Robinson; Larry S McDaniel
Journal:  MBio       Date:  2016-03-22       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.